Duk Lee - Blog & Notes

Writing

• Oct 6, 2026
  Recursion Pharmaceuticals ($RXRX) Deep Dive: 13 Years, $500M+ in Milestones, and Zero Approved Drugs — A Forensic Audit of TechBio's FlagshipMarket ↗
• Oct 6, 2026
  The 'Mouse Genome' Trap: Why Martin Shkreli's HGSI Analogy Exposes the Core Illusion of AI BioMarket ↗
• Oct 6, 2026
  Hacker News Front Page Roundup — October 6, 2026
• Oct 5, 2026
  Why Martin Shkreli Wants to Short $TWST, $DNA, and $RXRX: A Forensic Audit of 'AI Drug Dev' vs. Clinical RealityMarket ↗
• Oct 5, 2026
  Hacker News Front Page Roundup — October 5, 2026